<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human antibody responses to latent membrane protein 1 (LMP1) in patients with Epstein-Barr virus (EBV)-related disease syndromes were analyzed in detail </plain></SENT>
<SENT sid="1" pm="."><plain>Only by immunoblot analysis with purified recombinant LMP1 and by IFA on recombinant LMP1-expressing insect cells could human antibodies directed against LMP1 be detected </plain></SENT>
<SENT sid="2" pm="."><plain>Low serum levels of LMP1-directed antibodies could be detected in 3 of 8 EBV-positive <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> patients, 3 of 40 nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> patients, 2 of 23 Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients, and 1 of 27 non-Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients </plain></SENT>
<SENT sid="3" pm="."><plain>No LMP1-directed antibodies could be detected in healthy EBV carriers, <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> patients, or patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> EBV disease </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> sera contained significant levels of EBV antibodies directed against the immunodominant EBV proteins and <z:chebi fb="7" ids="16670">peptides</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>From this study, it can be concluded that LMP1 is a protein with a very low immunogenicity for the humoral immune response in humans </plain></SENT>
</text></document>